癌症与p53科普 The tumor suppressor gene p53 undergoes mutations in half of cancer patients, with varying mutation frequencies across different types of cancer 2022年5月30日
癌症与p53科普 Loss of anti-tumor function after p53 mutation is one of the main factors leading to cancer occurrence and death 2022年5月30日
癌症与p53科普 Although these over 1000 p53 mutations all cause p53 to lose its anti-tumor function, there are multiple pathways through which they cause p53 to lose its function. Therefore, different p53 mutants cannot be confused 2022年5月30日
癌症与p53科普 The research on p53 targeted drugs (i.e. drugs that can restore the anti-cancer function of p53 mutants) is highly challenging for two reasons 2022年5月30日
癌症与p53科普 Although at least 45 teams worldwide are researching drugs to treat p53 mutations, currently only arsenic agents can target p53 mutants and restore their anti-cancer function 2022年5月30日
癌症与p53科普 Even if arsenic agents have therapeutic effects, they are only effective against structural p53 mutants 2022年5月30日
癌症与p53科普 Large scale double-blind randomized controlled clinical trials are the only basis for determining the effectiveness of anti-cancer drugs 2022年5月30日